Foot (Edinburgh, Scotland) · 2026
Does the presence of calcaneal spurs with associated oedema in plantar fasciitis affect the outcome of shockwave therapy?
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Barnett James R, Imtiaz Hassan, Hegde Ganesh, Benfield Joanna, Singh Dishan, Patel Shelain, Cullen Nicholas, Malhotra Karan, Welck Matthew
Аннотация
BACKGROUND: Extra-corporeal shockwave therapy (ESWT) is commonly used for plantar fasciitis (PF). Calcaneal spurs have up to 80% prevalence in PF. The objective was to assess whether calcaneal spurs with associated oedema affect the outcomes of ESWT.
METHODS: Single-centre study of 30 patients over 3-years. Patients with confirmed diagnoses of PF on MRI scan who underwent ESWT were included. Patient reported outcomes scores (EQ5D / MOxFQ) were recorded pre-treatment and at 1-year post-ESWT.
RESULTS: Significant improvement (p < 0.001) in MOxFQ score and subjective improvement with ESWT in all patients. No difference in improvement of MOxFQ / EQ5D in patients with calcaneal spurs compared to without (p > 0.05). No correlation between presence of calcaneal spur oedema or spur size, and outcome scores (p > 0.05).
CONCLUSIONS: In this cohort, neither spur presence nor peri-spur oedema was associated with a significantly different response to ESWT. The majority of patients reported symptomatic improvement following ESWT (63.3%) and the.mean MOxFQ Index improvement across the cohort exceeded the published minimum clinically important difference.
LEVEL OF EVIDENCE: Level III, retrospective cohort study.
METHODS: Single-centre study of 30 patients over 3-years. Patients with confirmed diagnoses of PF on MRI scan who underwent ESWT were included. Patient reported outcomes scores (EQ5D / MOxFQ) were recorded pre-treatment and at 1-year post-ESWT.
RESULTS: Significant improvement (p < 0.001) in MOxFQ score and subjective improvement with ESWT in all patients. No difference in improvement of MOxFQ / EQ5D in patients with calcaneal spurs compared to without (p > 0.05). No correlation between presence of calcaneal spur oedema or spur size, and outcome scores (p > 0.05).
CONCLUSIONS: In this cohort, neither spur presence nor peri-spur oedema was associated with a significantly different response to ESWT. The majority of patients reported symptomatic improvement following ESWT (63.3%) and the.mean MOxFQ Index improvement across the cohort exceeded the published minimum clinically important difference.
LEVEL OF EVIDENCE: Level III, retrospective cohort study.